Advertisement
Loading...

UCB SA

UCBJYPNK
Healthcare
Biotechnology
$138.82
$4.72(3.52%)
U.S. Market is Open • 15:53

UCB SA (UCBJY) Stock Overview

Explore UCB SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap51.8B
P/E Ratio28.75
EPS (TTM)$4.70
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$125.82
3 Months$158.02
1 Year Target$179.52

UCBJY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of UCB SA (UCBJY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $179.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 28.75 and a market capitalization of 51.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.51%
5-Day Change
-2.60%
1-Month Change
-11.26%
3-Month Change
-18.53%
6-Month Change
2.78%
Year-to-Date (YTD) Change
-2.60%
1-Year Change
50.86%
3-Year Change
185.55%
5-Year Change
186.39%
All-Time (Max) Change
807.47%

Contact Information

32 2 559 99 99
Allée de la Recherche, 60, Brussels, NaN, 1070

Company Facts

9,052 Employees
IPO DateAug 3, 2012
CountryBE
Actively Trading

Frequently Asked Questions